- Display 15 Products per page
Published: December 1, 2008 | Price: $995.00 – $1,990.00
Biophotonics describes the use of photonics in biomedical applications. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. Among the different types of microscopy and associated technologies essential to the applications of biophotonics...Published: January 1, 2009 | Price: $995.00 – $7,000.00
In 2009, Electronic Medical Record (EMR) is the core focus of most health information technology offerings. Government initiatives (most recently stimulus bill EMR provisions) and cost concerns are key drivers of EMR and will continue to drive purchases of EMR systems in the near future. Technologies such as patient monitoring systems and handheld devices will need to adapt to EMR systems to thrive. Those seeking to understand the health IT market will need to build products that address the need...Published: January 1, 2009 | Price: $995.00 – $3,000.00
The gastrointestinal endoscopy market is a market on the rise. With continually advancing technologies available and world population increasing every year, the gastrointestinal endoscopy market. Market Driven by Aging Population, Growth in GI Disease Cases Growth in this market encompasses many areas with surgery being the majority of the increase. Cancer is one of leading reasons for surgery with more than 1 million new cases of colon/rectum cancer reported each year around the world. Obesity is another reason for growth....Published: January 1, 2009 | Price: $995.00 – $7,000.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the...Published: January 1, 2009 | Price: $995.00 – $1,990.00
The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets. For the...Published: February 1, 2009 | Price: $995.00 – $5,000.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...Published: February 1, 2009 | Price: $995.00 – $5,990.00
Women’s health encompasses all different areas of medicine and it would be a monumental task to address all of the areas that affect women. This report will concentrate on disorders that affect the female reproductive system and other disorders where there is at least a 70% preponderance of women affected by the disorder. The worldwide prescription drug market for women’s health consists of total manufacturers’ revenues from the following product categories: Autoimmune diseases Cancer Gynecological and Sexually Transmitted Diseases Hormones...Published: February 1, 2009 | Price: $995.00 – $3,000.00
This Kalorama report, Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants provides market size and forecast for the most utilized orthopedic devices. A global report, the business is calculated and forecasted for the United States, Europe, Asia and Rest of World. This report should be of interest to both the established and new entrant CM’s that are engaged in customer retention with existing revenues and established business, or generating new revenue streams from the high growth medical...Published: March 1, 2009 | Price: $995.00 – $5,990.00
Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Kalorama's Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers. represents the fourth time that Kalorama has rexamined this aspect of the wound care market, and the study analyzes the market using the following product...Published: April 1, 2009 | Price: $995.00 – $7,000.00
The dialysis industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - only 1.8 million dialysis patients form its entire...Published: April 1, 2009 | Price: $995.00 – $7,000.00
Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and...Published: April 1, 2009 | Price: $995.00 – $2,590.00
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including: Market Size and Forecast...Published: May 1, 2009 | Price: $995.00 – $7,000.00
The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades. This report, World Veterinary Health Products, takes a look at veterinary health products for both companion (pet) animals, and production animals (livestock and poultry) and the opportunity for existing players and...Published: May 1, 2009 | Price: $995.00 – $7,000.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of this decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's...Published: May 1, 2009 | Price: $995.00 – $7,990.00
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The...